Page 192 - Small Animal Internal Medicine, 6th Edition
P. 192

164    PART I   Cardiovascular System Disorders


                                                                 inhibitor (ACEI), or spironolactone have been performed,
                                                                 but clear benefit from any of these interventions has yet to be
  VetBooks.ir                                                    proven. With this in mind, some clinicians still suggest using
                                                                 a β-blocker in cats with evidence of substantial dynamic LV
                                                                 outflow obstruction or arrhythmias. In cats with marked,
                                                                 nonobstructive myocardial hypertrophy, particularly with
                                                                 evidence of myocardial fibrosis and remodeling, an ACEI
                                                                 might be suggested. For cats with LA enlargement, especially
                                                                 with spontaneous echocontrast, instituting antithrombotic
                                                                 prophylaxis with clopidogrel is prudent (see Chapter 12).
                                                                   Avoidance of stressful situations likely to cause persis-
                                                                 tent tachycardia and reevaluation on a semiannual or annual
                                                                 basis are usually advised. Secondary causes of myocardial
                                                                 hypertrophy, such as systemic arterial hypertension and
                                                                 hyperthyroidism, should be ruled out (or treated, if found).

                                                                 CONGESTIVE HEART FAILURE
                                                                 (STAGE C DISEASE)
            FIG 8.4
            Right parasternal short-axis echocardiographic image   Goals of therapy are to enhance ventricular filling, relieve
            obtained at the level of the heart base in a 5-year-old   congestion, control arrhythmias, minimize ischemia, and
            female domestic shorthair cat with hypertrophic      prevent thromboembolism (Box 8.1). Furosemide is used
            cardiomyopathy. Note the massive left atrial enlargement   only at the dosage needed to help control congestive signs
            and thrombus (arrows) within the auricle. Ao, Aorta; LA, left
            atrium; RV, right ventricle.                         for long-term therapy. Moderate to severe pleural effu-
                                                                 sion is treated by thoracocentesis, with the cat restrained
                                                                 gently in sternal position (and sedated with butorphanol
                                                                 if needed).



































              A                                               B

                          FIG 8.5
                          (A) Two-dimensional echo image in midsystole from a middle-aged domestic shorthair cat.
                          Echoes from the anterior mitral leaflet appear within the LV outflow tract (arrow) because
                          of abnormal systolic anterior (toward the septum) motion (SAM) of the valve. (B) The
                          M-mode echocardiogram at the mitral valve level also shows the mitral SAM (arrows). Ao,
                          Aorta; LA, left atrium; LV, left ventricle.
   187   188   189   190   191   192   193   194   195   196   197